← SynDRA
ETRUMADENANT
SynDRA canonical compound SYN0040208 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADORA2A | ADORA2B |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
| Indication | non-small cell lung cancer (nsclc) |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
- ADORA2B ANTAGONIST
- Adenosine A2b receptor antagonist
- adenosine receptor antagonist
Cross-references
Synonyms
- AB928
- AB-928
- AB 928
- Etrumadenant [USAN]
- W0ZE0NT8IF
- UNII-W0ZE0NT8IF
- ETRUMADENANT [INN]
- ETRUMADENANT [WHO-DD]
- RefChem:139303
- A2AR/A2BR Antagonist AB928
- Dual A2AR/A2BR Antagonist AB928
- Adenosine A2A/A2B Receptor Antagonist AB928
- C23H22N8O
- A2aR/A2bR antagonist-1
- trumadenant
- U30
- MFCD32263040
- Etrumadenant (USAN/INN)
- orb1308703
- SCHEMBL20401465
- SCHEMBL29393659
- SCHEMBL29560949
- SCHEMBL29659112
- GTPL11154
- GLXC-23113
- EX-A3172
- AB928?
- BDBM50594625
- EBC-14813
- NSC823658
- WHO 11620
- ZB1610
- AKOS037649091
- NSC-823658
- AC-36346
- BS-16547
- SY267925
- HY-129393
- CS-0105184
Look up ETRUMADENANT in the interactive SynDRA portal →